Tongling Jieya Biologic Technology Past Earnings Performance
Past criteria checks 1/6
Tongling Jieya Biologic Technology's earnings have been declining at an average annual rate of -12.2%, while the Personal Products industry saw earnings growing at 9.8% annually. Revenues have been declining at an average rate of 22.2% per year. Tongling Jieya Biologic Technology's return on equity is 4.9%, and it has net margins of 14.7%.
Key information
-12.2%
Earnings growth rate
-20.5%
EPS growth rate
| Personal Products Industry Growth | 7.8% |
| Revenue growth rate | -22.2% |
| Return on equity | 4.9% |
| Net Margin | 14.7% |
| Next Earnings Update | 28 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Tongling Jieya Biologic Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 624 | 92 | 58 | 23 |
| 31 Dec 23 | 623 | 115 | 54 | 23 |
| 30 Sep 23 | 588 | 106 | 55 | 24 |
| 30 Jun 23 | 587 | 117 | 49 | 23 |
| 31 Mar 23 | 614 | 131 | 43 | 24 |
| 01 Jan 23 | 667 | 141 | 40 | 25 |
| 30 Sep 22 | 696 | 164 | 36 | 26 |
| 30 Jun 22 | 717 | 172 | 31 | 26 |
| 31 Mar 22 | 818 | 185 | 28 | 30 |
| 01 Jan 22 | 984 | 220 | 30 | 36 |
| 30 Sep 21 | 1,024 | 243 | 25 | 38 |
| 30 Jun 21 | 1,103 | 252 | 20 | 41 |
| 31 Mar 21 | 956 | 229 | 22 | 35 |
| 31 Dec 20 | 743 | 180 | 22 | 27 |
| 31 Dec 19 | 307 | 68 | 18 | 11 |
| 31 Dec 18 | 312 | 58 | 24 | 11 |
| 31 Dec 17 | 243 | 26 | 25 | 9 |
Quality Earnings: 301108 has high quality earnings.
Growing Profit Margin: 301108's current net profit margins (14.7%) are lower than last year (21.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301108's earnings have declined by 12.2% per year over the past 5 years.
Accelerating Growth: 301108's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 301108 had negative earnings growth (-29.8%) over the past year, making it difficult to compare to the Personal Products industry average (-0.2%).
Return on Equity
High ROE: 301108's Return on Equity (4.9%) is considered low.